Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 503
Ph III recruiting: 45
Growth YoY: +18.8%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 901–950 of 1,127 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06938906	Multimodal Therapy Impact on Pancreatic Cancer Survival(MMTIPS)	active not recruiting	—	405	National Cheng Kung UniversityOTHER	1	Apr 24, 2025	clinicaltrials
NCT05518643	Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes	recruiting	—	120	University of ThessalyOTHER	1	Apr 22, 2025